James C. Yang

基本信息

浏览量：646

职业迁徙

个人简介

Dr. Yang is involved in the clinical and scientific study of T-cell adoptive therapy and other immunotherapies to treat melanoma and other cancers. He is particularly interested in expanding these modalities to other cancers such as renal, lung and thyroid cancer and is initiating these clinical protocols. His laboratory efforts have concentrated on the development of novel antigen receptors for T-cells with optimized specificity and efficacy in treating cancers.

研究兴趣

论文共 368 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

11P Patritumab deruxtecan (HER3-DXd) in previously treated patients (pts) with advanced EGFR-mutated (EGFRm) NSCLC: Updated safety results from HERTHENA-Lung01

H. Hayashi, Y. Goto,H.A. Yu,P.A. Jänne,J.C-H. Yang,M. Reck,K. Yoh, S-H. Lee,L. Paz-Ares,B. Besse,P. Bironzo,D-W. Kim,Z. Piotrowska,M.L. Johnson, A. Sporchia, K.H. Sullivan,Q. Dong,P. Shrestha, J. Shah,E. Felip

ESMO Open (2024)

引用0浏览0引用

38P Real-world Treatment Patterns and Effectiveness of Subsequent Treatments Following First-Line (1L) Brigatinib for Patients with Anaplastic Lymphoma Kinase Positive (ALK+) Non-Small Cell Lung Cancer (NSCLC) from ALTA-1L

A. Delmonte,M-J. Ahn, S. Ghosh,M.J. Hochmair,T-Y. Yang,J.C-H. Yang,J-Y. Han, K.H. Holmskov, Y. Wu, Y. Wan, M. Lin, J. Kretz, B. Hupf, A.M. Kurec,E. Churchill,R. Fram, C.J. Cabasag, V. Goriya, Y. Zhao,M.R. García Campelo

ESMO Open (2024)

引用0浏览0引用

Translational Insights and Overall Survival in the U31402-A-U102 Study of Patritumab Deruxtecan (Her3-Dxd) in EGFR-mutated NSCLC

H. A. Yu,C. Baik,D. -W. Kim,M. L. Johnson, H. Hayashi, M. Nishio,J. C. -H. Yang,W. -C. Su,K. A. Gold,M. Koczywas,E. F. Smit,C. E. Steuer,E. Felip, H. Murakami,S. -W. Kim, X. Su, S. Sato,P. -D. Fan, M. Fujimura, Y. Tanaka, P. Patel,D. W. Sternberg,D. Sellami,P. A. Jaenne

ANNALS OF ONCOLOGYno. 5 (2024): 437-447

引用0浏览0WOS引用

447 Clinical Factors Associated with Growth and Reactivity of Tumor Infiltrating Lymphocytes for Adoptive Cell Transfer in Patients with Metastatic Epithelial Cancers

Alexandra M Gustafson, Aaron J Dinerman, Kyle J Hitscherich, Maria Parkhurst, Hyunmi Halas,Donald White, Chuong Hoang, Jonathan M Hernandez, Mei Li Kwong, Nicholas D Klemen,Steven A Rosenberg, Stephanie L Goff,James C Yang

Regular and Young Investigator Award Abstracts (2024)

引用0浏览0引用

Amivantamab Plus Lazertinib Versus Osimertinib in First-Line EGFR-mutant Advanced Non-Small Cell Lung Cancer with Biomarkers of High-Risk Disease: a Secondary Analysis from MARIPOSA

E. Felip,B. C. Cho, V Gutierrez,A. Alip,B. Besse, S. Lu,A. I. Spira,N. Girard,R. Califano,S. M. Gadgeel,J. C-H. Yang, S. Yamamoto, K. Azuma,Y. J. Kim, K. -H. Lee,P. Danchaivijitr, C. G. Ferreira,Y. Cheng,M. A. N. Sendur,G. -C. Chang, C. -C. Wang, K. Prabhash, Y. Shinno, D. Stroyakovskiy, L. Paz-Ares, J. R. Rodriguez-Cid, C. Martin, M. R. G. Campelo, H. Hayashi, D. Nguyen, P. Tomasini, M. Gottfried, C. Dooms, A. Passaro, M. Schuler, A. C. Z. Gelatti, S. Owen, K. Perdrizet, S. -H. I. Ou, J. C. Curtin, J. Zhang, M. Gormley, T. Sun, A. Panchal, M. Ennis, E. Fennema, J. M. Bauml, M. Daksh, S. Sethi, S. -H. Lee

ANNALS OF ONCOLOGYno. 9 (2024): 805-816

引用0浏览0WOS引用

Adoptive Transfer of Personalized Neoantigen-Reactive TCR-transduced T Cells in Metastatic Colorectal Cancer: Phase 2 Trial Interim Results